Abstract. To 
Abstract. To evaluate the heparin effects in vivo and in vitro on adrenal angiotensin II receptors and angiotensin II-induced aldosterone production, we examined the angiotensin II binding and the maximum angiotensin II-induced aldosterone production using adrenal glomerulosa cells from rats treated with a heparin preparation containing benzyl alcohol (1500 IU/kg, twice daily for 6 weeks) or cells to which heparin (300 IU/l) was directly added. Comparison was made using the cells from rats treated with vehicle or the cells to which vehicle was directly added. Specific binding of [125I] iodo-angiotensin II was decreased in the cells from heparin-treated rats or in the heparin-treated cells. Scatchard analysis showed that the decrease in binding was due to a decrease in both the number and the affinity of angiotensin II receptors in the cells from heparin-treated rats and a decrease in the number, but not the affinity, of the receptors in the heparin-treated cells. Heparin also caused a decrease in the maximum angiotensin Il-induced production, but not the basal production, of aldosterone in the cells from hepari n\x=req-\ treated rats and in the heparin-treated cells. These data suggest that heparin interacts with adrenal angiotensin II receptors to inhibit the angiotensin Il-induced aldosterone production.
Heparin has been shown to cause a selective aldosterone deficiency with normo-or hyperreninemia in man (Bailey & ). The primary lesion caused by heparin has been thought to be at the adrenal zona glomerulosa because of the lack of renin suppression. In previous studies Uchida et al. 1986 ), we found a selective reduction of the aldosterone response to angiotensin II (All) in both adrenal zona glome¬ rulosa cells from rats treated with heparin in vivo and the cells to which heparin was directly added in vitro. Since the in vivo heparin treatment also inhibits all the maximum All-induced production of the aldosterone precursors, pregnenolone, corticosterone and 18-hydroxycorticosterone , it is possible that heparin causes an inhibition in adrenal All receptors rather than a selective impairment of enzyme activity in aldosteronogenesis, leading to a reduc¬ tion of All-induced aldosterone production.
To assess this possibility, we examined the ef¬ fects of heparin treatments in vivo and in vitro on adrenal All receptors and All-induced aldoste¬ rone production in rats. (Valient et al. 1964; Wilson & Goetz 1964) .
Materials and Methods
Heparin also caused a decrease in the maxi¬ mum All-induced production, but not the basal production, of aldosterone in the cells from hepa¬ rin-treated rats and in the cells to which heparin was directly added. No data on the heparin effect in vitro on the production of the precursor ster¬ oids of aldosterone are available. In our previous report ), however, the glome¬ rulosa cells from rats treated with heparin in vivo exhibited a decrease in the maximum All-in¬ duced production, but not the basal production, of pregnenolone, corticosterone, 18-hydroxycorticosterone as well as aldosterone, suggesting that the site of the inhibitory action of heparin is prior to the early step of the aldosterone biosynthetic pathway. Thus, the present inhibitory effects of heparin in vivo and in vitro on both adrenal All receptors and All-induced aldosterone produc¬ tion, together with our previous data, suggest that heparin interacts with adrenal All receptors to inhibit the All-induced aldosterone production.
In rats, All is well known to up-regulate its own receptors in adrenal glomerulosa cells in contrast to the down-regulation seen in vascular smooth muscle receptors (Douglas & Brown 1982 
